PAR-2 Deficient CD4+ T Cells Exhibit Downregulation of IL-4 and Upregulation of IFN-γ after Antigen Challenge in Mice  by Shichijo, Michitaka et al.
PAR-2 Deficient CD4+ T Cells Exhibit
Downregulation of IL-4 and
Upregulation of IFN- after Antigen
Challenge in Mice
Michitaka Shichijo1, Shinichi Kondo1, Mina Ishimori1, Shinichi Watanabe1, Heidi Helin1,
Tsugiko Yamasaki1, Mary E Stevens2, Florian Gantner1 and Kevin B Bacon1
ABSTRACT
Background: To investigate the functional role of protease activated receptor (PAR) -2 in T lymphocytes, we
analyzed TCR-mediated inflammatory cytokine production using PAR-2 deficient (KO) and wild type (WT)
mice.
Methods: Production of serum IgE and cytokines by spleen CD4+ T cells was determined in OVA-sensitized
and OVA-challenged mice of PAR-2 KO in contrast to WT mice. Phosphorylation of JNK1 and 2 was deter-
mined by Western blotting.
Results: A reduction in serum levels of IgE and IL-4 production by splenic CD4+ T cells from OVA-sensitized
and OVA-challenged KO mice compared to WT mice was observed. By contrast, IFN-γ production was upregu-
lated after antigen stimulation in KO mice. Anti-CD3-mediated phosphorylation of JNK1 was upregulated in
splenic CD4+ T cells from KO mice compared to WT mice.
Conclusions: PAR-2 participates in the regulation of T cell cytokine production that may be caused by modu-
lation of JNK1 phosphorylation.
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INTRODUCTION
Protease-activated receptors (PARs) are members of
the family of seven-transmembrane , G protein-
coupled receptors.1-3 Among the 4 PARs identified so
far , PAR-1, -3 and -4 are cleaved and activated by
thrombin , whereas PAR-2 is preferably cleaved by
trypsin, mast cell tryptase, factor VIIa and factor Xa.3-7
Each of the PARs has been shown to modulate a vari-
ety of physiological processes such as cytokine and
mediator release, vasodilatation, platelet aggregation,
cellular proliferation.4 A role for PAR-2 in inflamma-
tion has been suggested by demonstration of the fact
that PAR-2 mRNA was upregulated by IL-1α, TNF-α
or LPS in cultured human endothelial cells.8 In vivo,
activation of PAR-2 has been shown to induce various
inflammatory responses such as increased leukocyte
rolling and adherence in mesenteric venules,9 leuko-
cyte recruitment into the peritoneal cavity , 9 edema
formation and granulocyte infiltration in the rat paw.
10,11 Studies performed using PAR-2-deficient mice
have demonstrated that type IV allergic dermatitis in-
duced by picryl chloride or oxazolone was sup-
pressed in PAR-2 deficient mice.12 Further, Schmidlin
et al. reported that OVA-induced IgE production, air-
way eosinophilia and hyperreactivity to methacholine
were impaired in PAR-2 KO mice.13 Using clinical bi-
opsy specimens, up-regulation of PAR-2 expression in
respiratory epithelium from patients with asthma has
been observed.14 Together, these results clearly sug-
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Fig. 1 OVA-induced serum IgE-production and anti-CD3-induced production of IL-4 and IFN-γ from 
splenic CD4 ＋ T cels in WT and PAR-2 KO mice. Mice were sensitized and chalenged with OVA (OVA) or 
sensitized with alum alone (Sham) as described in the Methods. Twenty-four hours after final chalenge 
mice were euthanized, and sera and spleens were colected. Splenic CD4 ＋ T cels were purified and then 
re-stimulated in pre-coated plates with 10 μg/ml anti-CD3 mAb for 48 hours. The amount of IgE in serum, 
and cytokines in cel supernatants were measured by ELISA. Columns represent mean ± SEM of 5―7 
mice.
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gest that PAR-2 plays a significant role in allergic air-
way inflammation.
Allergic asthma is a complex inflammatory disease
associated with airway hyperresponsiveness (AHR),
infiltration of eosinophils into the bronchial wall and
lumen, mucus production in the airways and elevated
serum IgE levels.15,16 CD4+ Th2 cells and their cy-
tokine products, including IL-4, 5, 9 and 13, play criti-
cally important roles in the pathogenesis of asthma.17
Adoptive transfer of effector Th2 cells into naïve
mice followed by exposure to inhaled antigen induces
the pathophysiological features of asthma,18 demon-
strating that these cells are fully capable of inducing
the asthma phenotype.
In this study, we made use of PAR-2 knockout mice
to examine the role of PAR-2 in cytokine production.
In the model of OVA-induced airway inflammation,
the cytokine pattern of T cells from PAR-2 KO and
wild type (WT) mice were compared. Furthermore,
cytokine secretion, gene expression in naïve T cells
from PAR-2 KO and WT mice were analysed. To de-
termine the difference of cellular signal, phosphoryla-
tion of JNKs in naïve CD4+ T cells was also investi-
gated.
METHODS
GENERATION OF PAR-2-DEFICIENT MICE
Mouse PAR-2 genomic clones were obtained by PCR
amplification. A targeting vector was constructed by
subcloning the genomic DNA, a hygromycin select-
able marker, and a lox P sequence into the ppNTT-
neo vector. Ten mg of the targeting vector was intro-
duced into RW4 ES cells by eletroporation and stable
clones were selected by culturing the cells for 10 to
12 days in the presence of 260 μgml of G418. The
clones were injected into C57 blastocytes. Germline
transmission of the disrupted locus was confirmed by
backcrossing the chimeric males to C57 females, and
the homozygous knockout mice were obtained by
crossing the chimeric males to 129SvJ females. Con-
trol mice (B6129 F2J) were purchased from Jackson
Laboratory (West Grove, PA, USA) according to their
recommendation . 19 S129SvJ background mice and
their WT counterparts ( Jackson Laboratory ) were
272 Allergology International Vol 55, No3, 2006 www.jsaweb.jp
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Fig. 2 Expression of mRNA for GATA-3 and T-bet after in vitro polarization of splenic CD4 ＋T 
cels toward Th1 or Th2. Purified splenic naïve CD4 ＋T cels were cultured in the condition toward 
Th1 or Th2 (see Methods). After culture for 3 days, cels were lysed with Trizol, RNA was extracted 
and the expression levels of GATA-3 and T-bet were detected by electrophoresis or quantitatively 
measured by light cycler. Data shown represent one out of 2 independent experiments with identi-
cal results.
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also used as described in previous studies.13
Animals were kept under standard conditions in a
12 h daynight rhythm with free access to food and
water ad libitum. All animals received human care
and the studies were approved by the internal ethic
committee in accordance with the guidelines recom-
mended by JALAS (Japanese Association of Labora-
tory Animal Science).
OVA-INDUCED IgE PRODUCTION
Mice were sensitized by intraperitoneal (i.p.) injec-
tions of 100 μg of ovalbumin (OVA , chicken egg ,
Grade V, Sigma-Aldrich, St.Louis, MO, USA) and 20
mg of alum (aluminium potassium sulfate dodecahy-
drate, Sigma-Aldrich) in 200 μl of saline on days 0 and
14. Mice in the sham group received i.p. injections of
20 mg of alum in 200 μl of saline. On days 14, 18 and
22, mice were challenged by intranasal (i.n.) admini-
stration of 100 μg of OVA in 40 μl of saline. Mice in
the sham group received i.n. administration of 40 μl
of saline only. Total IgE level in serum was measured
by ELISA (Yamasa Co., Tokyo, Japan).
CYTOKINE PRODUCTION
CD4+ T cells were separated by using the mouse CD4
negative selection kit and MACS system according to
the manufacturer’s instructions (Milteny , Bergisch
Gladbach , Germany) . Purified cells (purity >95%)
from WT and PAR-2 KO mice were suspended in
RPMI1640 containing 10% FBS and cultured at 2 × 105
cellswell in 96-well plates coated with anti-CD3 ε
mAb (10 μgml, PharMingen, San Diego, CA, USA)
for 48 hours at 37℃ in an incubator. The amount of
IL-2, IL-4, IL-13 and IFN-γ in the supernatants of the
cultured cells was measured by ELISA (Genzyme
Techne, Minneapolis, MN, USA).
POLARIZATION OF CD4+ T CELLS
Purified CD 4+ cells were cultured under Th 1-
favouring conditions in the presence of 5 μgml anti-
CD28 mAb (PharMingen) , 50 IUml IL-2 (Pepro
Tech, Inc . , Rocky Hill , NJ , USA) , 5 ngml IL-12
(Pepro Tech, Inc.) and 10 μgml neutralising anti-IL-4
mAb (PharMingen) or Th2-polarized conditions in
the presence of 5 μgml anti-CD28 mAb, 50 IUml IL-
2, 50 ngml IL-4 (PharMingen) and 10 μgml neutral-
ising anti-IFN-γ mAb (Pharmingen) as described in
previous report.20 After that, cells were restimulated
in 12 well plates pre-coated with 10 μgml anti-CD3ε
for 3 days. Total RNA from lysed cells was extracted
and PCR was performed to detect mRNA for GATA-3
(Th2-specific transcription factor) and T-bet (Th1-
Allergology International Vol 55, No3, 2006 www.jsaweb.jp 273
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Fig. 3 Anti-CD3-induced cytokine production from purified splenic naïve CD4 ＋T cels. Comparison of anti-CD3-
induced production of IL-2, IL-4, IL-13 and IFN-γ from splenic CD4 ＋T cels between WT and KO of B6129 back-
ground mice (A). Anti-CD3-induced IL-4 production from Th2 polarized cels of S129 background WT and PAR-2 
KO mice (B). Purified naïve CD4 ＋ T cels were cultured in 10 μg/ml anti-CD3 pre-coated plates for 48 hours. The 
amount of cytokines were measured by ELISA. Data represent mean ± SEM of 3―6 experiments. Significant dif-
ference between WT and PAR-2 KO T cels: ＊P ＜ 0.05.
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specific), respectively.
DETECTION OF mRNA EXPRESSION BY REAL-
TIME PCR
Total RNA was isolated from CD4+ T cells after polari-
zation into Th1 or Th2. The first strand cDNAs were
synthesised with random hexamer primers and Su-
perscriptTM II RNase H- reverse transcriptase (Invi-
trogen, San Diego, CA, USA). The PCR product for
GATA-3 and T-bet obtained in the dual PCR reaction
was measured by SYBR green using LightCycler
(Roche Diagnostics Co., Indianapolis, IN, USA). De-
tection temperature was 88℃ for GATA-3, 86℃ for T-
bet and 80℃ for β2 microglobulin, and the annealing
temperature was 65℃ for all molecules. The follow-
ing primers were used : mouse GATA-3, 5 ’ -
tcactctcgaggcagcatgaccac-3 ’ and 5 ’ -
tcacacactccctgccttctgtgc-3 ’ ; mouse T-bet , 5 ’ -
ggttggaggtgtctgggaagctga-3 ’ and 5 ’ -
ggtgctggtccaccaagaccacat-3’;mouse β2 microglobulin
for a standard , 5 ’ -gagaatgggaagccgaaca-3 ’ and 5 ’ -
tatcagtctcagtgggggtg-3’.
WESTERN BLOT ANALYSIS
For the determination of CD3-mediated phosphoryla-
tion of JNKs , purified CD4+ T cells from WT and
PAR-2 KO mice were stimulated with 10 μgml anti-
CD3ε mAb or a combination of 20 ngml PMA and 1
μM A23187 calcium ionophore for 15 minutes. Cells
were lysed in lysis buffer (20 mM Tris, pH7.5, 1 mM
EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium
pyrophosphate , 1 mM β-glycerol phosphate , 1 mM
Na3VO4 and protease inhibitor cocktail (Roche Diag-
nostics GmbH, Mannheim, Germany)). The samples
were separated by 10% SDS-polyacryl-amide gel elec-
trophoresis . Gels were transferred to Immun Blot
PVDF membrane and then incubated with blocking
solution (5% skim milk in TBS, 0.1% Tween 20) for 60
minutes and then incubated with anti-phospho-
SAPKJNK (Thr183Tyr185) (Cell Signaling) and
anti-SAPKJNK (New England BioLabs, inc. , MA,
USA) diluted at 11000 with skim milk. Membranes
were then washed and peroxidase-labeled anti-rabbit
IgG (SantaCruz, CA, USA) diluted at 15000 with
skim milk was incubated for 60 minutes. Membrane
bound antibody was visualized using ECL detection
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Fig. 4 Phosphorylation and expression of JNKs in CD4 ＋T cels. Purified 
CD4 ＋ T cels were stimulated with 10 μg/ml anti-CD3 or a combination of 
20 ng/ml PMA and 1 μM A23187 calcium ionophore for 15 minutes. Cels 
were lysed and separated by gel electrophoresis. Transfered membrane 
was incubated with anti-phospho-SAPK/JNK or anti-SAPK/JNK and then in-
cubated with peroxidase-labeled anti-rabbit IgG. Membrane bound anti-
body was visualized by ECL detection reagent.
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reagent (Amersham Biosciences, UK).
STATISTICAL ANALYSIS
Statistical significance of results comparing WT and
KO mice, or sham treatment and OVA treatment was
determined by Student’s t-test for paired data. Differ-
ences were considered to be significant at the P <
0.05 (*P < 0.05, **P < 0.01). All data are expressed as
the mean ± SEM.
RESULTS
EXPRESSION OF PAR-2 mRNA
To verify the KO phenotype we compared PAR-2
mRNA expression levels in various tissues from WT
and KO mice by RT-PCR using mouse-specific PAR-2
primers ( 5 ’ -tctggatcttccttttccgaacg-3 ’ and 5 ’ -
tacgagcagaaggttgctaggagc-3 ’ ) . Spleen , thymus and
liver from WT mice highly expressed PAR-2 mRNA
whereas no signal at all was detectable in tissues
from KO mice (data not shown).
REDUCTION OF IgE AND ANTI-CD3-TRIGGERED
IL-4 PRODUCTION IN KO MICE AFTER OVA-
STIMULATION
Reduced IgE production after OVA sensitization and
challenge of mice lacking PAR-2 has been previously
reported13,21 and was confirmed in our KO strain. As
shown in Figure 1A, significantly lower levels of IgE
in the serum of OVA-sensitized and OVA-challenged
KO mice compared to WT counterparts were ob-
served. To investigate whether reduced IgE was a
consequence of changes in cytokine production, we
checked the Th1 and Th2 cytokine productivity by
WT and KO mice. CD3-induced production of IL-4
and IFN-γ by spleen CD4+ T cells after sham or OVA-
treatment was determined. Indeed, the release of IL-4
by CD4+ T cells from PAR-2 deficient mice was sig-
nificantly reduced both after sham and OVA-
treatment compared to WT mice (Fig . 1B). OVA
stimulation tended to impair the CD3-induced IL-4
and IFN-γ production in WT cells compared to sham-
treatment (Fig. 1B), suggesting that repeated stimu-
lation by OVA might reduce cytokine production ca-
pabilities of splenocytes. Interestingly, the production
of IFN-γ from CD4+ T cells was significantly higher in
OVA-treated KO mice compared to OVA-treated WT
mice or sham-treated KO mice (Fig. 1C).
SUPPRESSION OF GATA-3 AND UPREGULA-
TION OF T-BET IN PAR-2 DEFICIENT CELLS
To further study the reduction of Th2 cytokine pro-
duction after Th polarization in KO mice in vitro, puri-
fied naïve spleen CD4+ T cells were lead to a Th2 or
Th1 phenotype. The expression levels of Th subtype-
specific transcription factors GATA-3 (Th2) and T-bet
(Th1) were determined. As shown in Figure 2A, high
expression of GATA-3 mRNA was observed and
clearly reduced expression levels were seen in KO
cells in comparison to WT samples after polarization
of cells to Th2. In contrast, when cells were polarized
to Th1, clear expression of T-bet mRNA was ob-
served and T-bet expression levels were up-regulated
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in KO cells in comparison to WT cells (Fig. 2B).
CYTOKINE PROFILE OF NAVE CD4+ T CELLS
Since cytokine production not only differed between
WT and PAR-2 deficient mice after OVA treatment
but also after sham treatment (Figs. 1B, 1C), we next
checked the cytokine profile of naïve CD4+ T cells.
Since the background of our KO mice was a crossing
between C57BL6 and S129SvJ (see Methods for de-
tails), we first checked the cytokine production capa-
bilities of those 3 mouse background strains. No sig-
nificant differences were apparent following anti-CD3-
induced production of IL-2, IL-4 and IFN-γ (data not
shown). When PAR-2 KO mice were compared with
the corresponding WT mice, a significant reduction
of CD3-mediated IL-4, IL-13 and IFN-γ but not IL-2 re-
lease from naïve CD4+ T cells of KO mice was ob-
served (Fig. 3A). This reduction in IL-4 protein secre-
tion by naïve CD4+ T cells was further confirmed us-
ing S129SvJ pure background mice (data not shown).
Moreover , a 35% reduction in IL-4 production was
also noted after anti-CD3 re-stimulation of Th2 polar-
ized cells from KO mice of the S129SvJ pure back-
ground when compared to WT cells (Fig. 3B).
EXPRESSION OF CD ANTIGENS AND MOLE-
CULES RELATED TO T CELL FUNCTION IN WT
AND KO CELLS
We then examined the protein expression of CD4 and
CD8 and transcript expression patterns of several
molecules related to T cell function to shed light on
the potential influence of PAR-2 deficiency on the dif-
ferentiation state andor subtype development of naï
ve T cells . Surface protein expression of CD4 and
CD8 both in spleen (CD4+CD8−; 31.9% in WT vs 32.3%
in KO, CD4−CD8+; 15.8% in WT vs 16.3% in KO) and
thymus (CD4+CD8+; 85.5% in WT vs 81.8% in KO, CD
4+CD8−; 11.7% in WT vs 12.6% in KO, CD4−CD8+; 3.0%
in WT vs 3.5% in KO) was unaffected by PAR-2 defi-
ciency when checked by flow cytometry (mean of 2
experiments).
EXPRESSION AND PHOSPHORYLATION OF
JNKS
The real-time RNA expression analysis by light cycler
revealed that the expression level of JunB, JNK1 and
JNK2 was not affected by PAR-2 deficiency (n = 3,
data not shown). Moreover, protein expression levels
of p46 JNK1 (Fig. 4), p54 JNK2 (Fig. 4) and JunB
(data not shown) were not affected by PAR-2 defi-
ciency. However, it is of interest that the phospho-
rylation of p46 JNK1 was clearly upregulated in KO
cells compared to WT cells, whereas p54 JNK2 was
not significantly affected by anti-CD3 stimulation (
Fig . 4). By contrast , stimulation with PMA and A
23187 calcium ionophore significantly induced phos-
phorylation of both JNK1 and JNK2 (Fig. 4).
DISCUSSION
Involvement of PAR-2 in immune-related disorders
has been suggested from in vivo studies using mice
deficient for PAR-2 expression. It has been reported
that eosinophil infiltration into the bronchoalveolar
space, airway hyperreactivity to methacholine and se-
rum IgE levels were suppressed in PAR-2 KO mice in
an OVA-induced asthma model13,21,22 in which Th2
cells play a dominant role. On the other hand, so-
called Th1-driven diseases, adjuvant arthritis 23 and
type IV allergic dermatitis,12 were also suppressed in
PAR-2 deficient mice. The pathogenesis of these dis-
eases involves multiple cell types and cytokines, yet a
common feature in these animal models is immuniza-
tion, implying a role of PAR-2 in affecting antigen-
induced immune reactions.
In the present study, we confirmed the previous re-
sults13,21 of the reduced level of serum IgE in PAR-2
KO mice after OVA challenge. Concomitantly, we ob-
served lower levels of IL-4 and higher levels of IFN-γ
production from splenic CD4+ T cells from PAR-2 KO
mice challenged with OVA. It was also acknowledged
that both IL-4 and IFN-γ were lower in KO mice un-
der sham treatment and only IFN-γ increased in re-
sponse to OVA challenge . The diminished respon-
siveness to TCR stimulation with regard to produc-
tion of Th1Th2 effector cytokines seems to be intrin-
sic to T cells of mice lacking PAR-2. Specifically ,
CD4+ T cells isolated from the spleens of untreated
mice, presumably naïve T-cells, readily showed re-
duced levels of IL-4, IL-13, and IFN-γ production in re-
sponse to anti-CD3 stimulation. The decreased pro-
duction of not only Th2 but also Th1 cytokines in the
naïve CD4+ T cell population may provide an expla-
nation for the suppressive effects of PAR-2 disruption
reported for both asthma13 and arthritis23 experimen-
tal animal models. Of particular interest in our results
is the increased production of IFN-γ from splenic CD
4+ T cells from PAR-2 KO mice challenged with OVA
(Fig. 1C) and the increased expression of T-bet , a
transcription factor regulating Th1 development , in
splenic CD4+ T cells of PAR-2 KO mice after in vitro
polarization towards Th1 (Fig . 2B). Regarding the
upregulation of Th1, it should be noted that in the in
vitro study at low concentrations of anti-CD3 Ab (less
than 10 μgml) the IFN-γ production by naïve PAR-2
KO T cells was downregulated, whereas at the high-
est concentration of anti-CD3 Ab (12.5 mgml) the
IFN-γ production was at a similar level with wild cells
(data not shown) . Therefore , IFN-γ production in
PAR-2 KO T cells might be changed by concentra-
tion, timing, kind and repetition of the stimulation,
which might have induced conflicted output on Th1-
and Th2-mediated experimental animal models.12,13,23
Of note, the level of IL-2 production from the naïve
T lymphocyte subset was not affected in PAR-2 KO
mice. Indeed, there was no difference between PAR-2
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KO and WT in in vitro T cell proliferation in response
to TCR stimulation (data not shown). Thus, it is un-
likely that the protective effects of PAR-2 disruption
in the animal experimental models associated with
immunological disorders are exerted by general im-
munosuppression.
The potential mechanisms that cause such an al-
teration of cytokine production from T cells are still
matters of speculation. One theoretical possibility is
that PAR-2 directly controls T cell function(s). In fact,
the PAR-2 activating peptide, SLIGKV, has been re-
ported to produce transient Ca2+ flux,24 tyrosine phos-
phorylation of Vav1, ZAP-70 and SLP-70 in human
Jurkat T cells25 suggesting functionally active PAR-2
expression on this particular T cell line. Indeed, we
detected a significant amount of PAR-2 transcript in
mouse peripheral CD4+ T cells by RT-PCR analysis
(data not shown). Nevertheless, mouse primary CD4+
T cells in the present study did not respond to any of
the PAR-2 activating peptides tested (SLIGRL or tc-
LIGRLO) with calcium flux, Erk phosphorylation, or
cytokine production (data not shown). Even when
calcium flux and cytokine production were induced in
combination with TCR activation no PAR-2 response
was observed (data not shown). Although the possi-
bility that PAR-2 might function at a certain stage of T
cell development cannot be fully ruled out , so far
there is no supporting evidence for a direct functional
role of PAR-2 in mouse T lymphocytes.
In an attempt to identify a pathway affected by
PAR-2 deficiency, we examined the expression of 32
genes including surface antigens, cytokine receptors,
transcription factors and kinases in CD4+ T cells with
microarray analysis (preliminary experiment, n = 1,
data not shown). Of the genes associated with T cell
function we have studied, none were influenced by
PAR-2 deficiency. Notably, the expressions of tran-
scripts and protein of JNK1, JNK2 and JunB were not
affected , however , phosphorylation of JNK 1 was
clearly upregulated in KO cells in comparison to WT
cells (Fig. 4). Activation but not expression of JNKs
has been reported to be required for T cell activa-
tion,26 therefore phosphorylation of JNK would affect
T cell signaling and development. Dong et al.27 dem-
onstrated that JNK1 deficient T cells preferentially
differentiated to Th2. Thus , upregulation of JNK1
might be associated with Th2 reduction andor Th1
upregulation in KO cells. Phosphorylation of JNK2,
whose deficiency leads to Th1 differentiation,28 was
not clearly affected in this study.
Recently , Fields et al. demonstrated that PAR-2
plays a role in the development of dendritic cells.29 In
their study, the differentiation of dendritic cells from
precursor cells induced by GM-CSF and IL-4 in vitro
was inhibited by serine protease inhibitors and by
gene disruption of PAR-2. Conceivably, dendritic cell
populations in PAR-2 KO mice might be different
from those in the WT control mice. Although further
studies are required to fully comprehend whether
particular dendritic cell subsets are affected by PAR-2
deficiency, it is intriguing to speculate that dendritic
cell development is implicated in the alteration of T
cell cytokine production in PAR-2 KO mice.
In conclusion, downregulation of IL-4 and upregu-
lation of IFN-γ after antigen challenge in mice lacking
PAR-2 were observed. Although the PAR-2 contribu-
tion to this phenomenon is not clear, PAR-2 may be
involved in initiating the development of cytokine pro-
ducing T cells at an early stage of development of the
T cell lineage.
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